New England Journal of Medicine

A caregiver talking to a wheelchair-bound patient
February 8, 2017

Social risk factors influence outcomes, Medicare payment

Social risk factors including income, education and ethnic background influence health outcomes and should be taken into account in Medicare payment models, according to a New England Journal of Medicine “Perspective” titled “Social Risk Factors and Equity in Medicare Payment.”

By Craig Boerner
Cropped shot of a group of business colleagues meeting in the boardroom
February 2, 2017

Study finds smaller insurers earning profits in new market

The researchers examine whether the financial struggles of some major insurers under the Affordable Care Act reflect a policy failure or a mismatch of these firms’ capabilities and strategies to a newly created market.

By Craig Boerner
January 26, 2017

Automation speeds clinical safety surveillance: study

Using patient outcomes data from approximately 1,800 hospitals, the largest demonstration to date of automated safety surveillance of a medical device is reported in this week’s New England Journal of Medicine.

By Paul Govern
November 3, 2016

Study details rare heart risk of certain cancer therapies

By VUMC News and Communications
October 27, 2016

Emerging field of cardio-oncology seeks better tools

Improved therapies have led to a spike in the number of people living with cancer, and today there are more than 15.5 million survivors in the United States. However, some of these therapies can cause toxicities to the heart, the vessels and the body’s metabolism.

By VUMC News and Communications
September 30, 2015

Reduced-nicotine cigarettes decreased dependence and frequency of smoking: NEJM study

Reduced-nicotine cigarettes were beneficial in reducing nicotine exposure and dependence, and also the number of cigarettes smoked per day, when compared with standard-nicotine cigarettes in a six-week study published in the New England Journal of Medicine.

By Craig Boerner
August 20, 2015

New type of trial shows promise for several cancers

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.
By VUMC News and Communications
August 6, 2015

New targeted therapy shows promise for rare joint tumor

Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities.
By VUMC News and Communications
February 26, 2015

Respiratory viruses are main childhood pneumonia culprit: Study

Respiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine.
By Christina Echegaray
January 15, 2015

New drugs approved to fight idiopathic pulmonary fibrosis

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).
By Kathy Whitney
August 21, 2014

Transfusions ease strokes for children with sickle cell

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes.
By Christina Echegaray
October 3, 2013

Study finds cognitive deficits common after critical illness

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine.
By Craig Boerner
July 11, 2013

Infant vaccine for pneumonia helps protect elderly

Children who receive a vaccine to prevent blood and ear infections may be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults.
By VUMC News and Communications
1 2 3 4 5